Assessment of liver disease in HIV/HCV co-infected patients
Not Applicable
- Conditions
- Health Condition 1: A638- Other specified predominantly sexually transmitted diseasesHealth Condition 2: A638- Other specified predominantly sexually transmitted diseases
- Registration Number
- CTRI/2021/04/032529
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HIV/HCV co-infected patients of more than 18 years
Exclusion Criteria
HIV with Hepatitis B infection
Portal HTN due to causes like hypercoaguable states
Dementia,TBM
MODS
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess clinical profile of HIV/HCV co- infected patientsTimepoint: At the end of 6 weeks
- Secondary Outcome Measures
Name Time Method Severity of liver disease will be assessed by <br/ ><br>FIB4 score and CTP scoreTimepoint: At the end of 6weeks